This modelrecapitulates the systemic manifestations of human plasma cell neoplasms, andimplicates cooperativity between the Rad50s andMef/Elf4 pathways in initiating myelomagenic mutations that promote plasma celltransformation. Here, ELF4 is linked to plasma cell neoplasm.